Canadian health authorities approved Amylyx Pharmaceuticals Inc.’s new drug for amyotrophic lateral sclerosis, the progressive neurodegenerative disease that robs patients of their ability to move and speak.
It is the first Canadian approval since 2018 for a new drug treating the fatal condition, which is also known as Lou Gehrig’s disease.
.jpg "The Weird Way That Human Waste Is Killing Corals")
The president-elect said this week he didn’t expect DeSantis to appoint Lara...
Silar via Wikimedia Commons In just a decade, we witnessed...
Join Fox News for access to this content You have...
I asked Amko Leenart, director of design for Ford Europe,...
Particles in ship exhaust inadvertently cause cloud brightening – some...
Justin Baldoni has been dropped by WME following Blake Lively’s...
